Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes | Zendy

Wendy Camelo Castillo | Zendy; Kim Boggess | Zendy; Til Stürmer‎ | Zendy; M. Alan Brookhart | Zendy; Daniel K. Benjamin | Zendy; Michele Jönsson Funk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes

Author(s) -

Wendy Camelo Castillo,

Kim Boggess,

Til Stürmer‎,

M. Alan Brookhart,

Daniel K. Benjamin,

Michele Jönsson Funk

Publication year - 2015

Publication title -

jama pediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.004

H-Index - 183

eISSN - 2168-6211

pISSN - 2168-6203

DOI - 10.1001/jamapediatrics.2015.74

Subject(s) - medicine , gestational diabetes , neonatal intensive care unit , obstetrics , hypoglycemia , respiratory distress , pregnancy , population , relative risk , cohort study , gestational age , pediatrics , insulin , confidence interval , gestation , surgery , genetics , environmental health , biology

Glyburide is thought to be safe for use during pregnancy for treatment of gestational diabetes mellitus (GDM). However, there are limited data on the effectiveness of glyburide when compared with insulin as used in a real-world setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research